Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allbirds, Inc. stock logo
BIRD
Allbirds
$7.04
+8.8%
$9.83
$3.93
$18.33
$57.35M1.972,717 shs57,343 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$264.67
+5.3%
$246.20
$184.80
$310.00
$10.32B0.4481,348 shs604,846 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allbirds, Inc. stock logo
BIRD
Allbirds
0.00%+0.14%-38.25%+6.67%-54.26%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%+4.62%+14.94%-1.51%+35.71%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allbirds, Inc. stock logo
BIRD
Allbirds
2.785 of 5 stars
3.31.00.00.02.33.31.3
Penumbra, Inc. stock logo
PEN
Penumbra
4.7777 of 5 stars
3.55.00.03.72.42.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allbirds, Inc. stock logo
BIRD
Allbirds
2.50
Moderate Buy$11.0056.25% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.94
Moderate Buy$300.4713.52% Upside

Current Analyst Ratings Breakdown

Latest RDT, BIRD, PEN, and CHSS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2025
Allbirds, Inc. stock logo
BIRD
Allbirds
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$5.00 ➝ $8.00
7/31/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$260.00 ➝ $266.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$300.00 ➝ $310.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$330.00 ➝ $325.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$330.00 ➝ $335.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$315.00 ➝ $290.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$283.00 ➝ $285.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$340.00 ➝ $350.00
7/18/2025
Penumbra, Inc. stock logo
PEN
Penumbra
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/9/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$320.00 ➝ $285.00
(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allbirds, Inc. stock logo
BIRD
Allbirds
$189.76M0.30N/AN/A$8.76 per share0.80
Penumbra, Inc. stock logo
PEN
Penumbra
$1.28B8.06$2.89 per share91.71$33.18 per share7.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allbirds, Inc. stock logo
BIRD
Allbirds
-$93.32M-$10.56N/AN/AN/A-49.36%-87.92%-48.49%11/5/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$3.7670.3952.832.3811.54%11.55%8.76%10/29/2025 (Estimated)

Latest RDT, BIRD, PEN, and CHSS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Allbirds, Inc. stock logo
BIRD
Allbirds
-$2.78-$1.92+$0.86-$1.92$38.44 million$39.69 million
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81$0.86+$0.05$1.15$327.37 million$339.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allbirds, Inc. stock logo
BIRD
Allbirds
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allbirds, Inc. stock logo
BIRD
Allbirds
0.07
2.55
1.41
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.75
4.04

Institutional Ownership

CompanyInstitutional Ownership
Allbirds, Inc. stock logo
BIRD
Allbirds
44.07%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%

Insider Ownership

CompanyInsider Ownership
Allbirds, Inc. stock logo
BIRD
Allbirds
30.67%
Penumbra, Inc. stock logo
PEN
Penumbra
4.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allbirds, Inc. stock logo
BIRD
Allbirds
7108.15 million5.65 millionNot Optionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50039.00 million37.36 millionOptionable

Recent News About These Companies

Adam Elsesser Sells 15,900 Shares of Penumbra (NYSE:PEN) Stock
Penumbra (PEN): Buy, Sell, or Hold Post Q2 Earnings?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allbirds stock logo

Allbirds NASDAQ:BIRD

$7.04 +0.57 (+8.81%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$7.09 +0.05 (+0.72%)
As of 08/22/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allbirds, Inc. manufactures and sells footwear and apparel products for men and women in the United States and internationally. The company offers a range of lifestyle and performance shoes; and apparel, including classic tees and sweats, socks, and underwear. It sells its products through its retail stores, as well as online. The company was formerly known as Bozz, Inc. and changed its name to Allbirds, Inc. in December 2015. Allbirds, Inc. was incorporated in 2015 and is headquartered in San Francisco, California.

Penumbra stock logo

Penumbra NYSE:PEN

$264.67 +13.30 (+5.29%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$264.74 +0.07 (+0.03%)
As of 08/22/2025 05:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.